These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27637864)

  • 1. Disease severity and erythropoiesis in chronic hepatitis C.
    Huang CF; Huang CI; Yeh ML; Hou C; Hou NJ; Hsieh MY; Huang JF; Chen SC; Lin ZY; Dai CY; Chuang WL; Yu ML
    J Gastroenterol Hepatol; 2017 Apr; 32(4):864-869. PubMed ID: 27637864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients.
    Petta S; Grimaudo S; Tripodo C; Cabibi D; Calvaruso M; Di Cristina A; Guarnotta C; Macaluso FS; Minissale MG; Marchesini G; Craxì A
    J Clin Endocrinol Metab; 2015 Jan; 100(1):193-200. PubMed ID: 25268393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum FGF21 and RBP4 levels in patients with chronic hepatitis C.
    Kukla M; Berdowska A; Stygar D; Gabriel A; Mazur W; Łogiewa-Bazger B; Sobala-Szczygieł B; Bułdak RJ; Rokitka M; Zajęcki W; Kępa L; Sawczyn T; Zwirska-Korczala K
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1037-47. PubMed ID: 22670657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
    Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
    Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C.
    Yadav D; Hertan HI; Schweitzer P; Norkus EP; Pitchumoni CS
    Am J Gastroenterol; 2002 Oct; 97(10):2634-9. PubMed ID: 12385452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.
    Huang JF; Huang CF; Yu ML; Dai CY; Huang CI; Yeh ML; Hsieh MH; Yang JF; Hsieh MY; Lin ZY; Chen SC; Chuang WL
    J Gastroenterol Hepatol; 2011 Mar; 26(3):530-5. PubMed ID: 21332548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between indirect bilirubin levels and liver fibrosis due to chronic hepatitis C virus infection.
    Cengiz M; Yılmaz G; Ozenirler S
    Pathol Res Pract; 2014 Aug; 210(8):488-93. PubMed ID: 24842533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients.
    Petta S; Marchesini G; Caracausi L; Macaluso FS; Cammà C; Ciminnisi S; Cabibi D; Porcasi R; Craxì A; Di Marco V
    J Hepatol; 2013 Dec; 59(6):1169-76. PubMed ID: 23933265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection.
    Petta S; Macaluso FS; Cammà C; Marco VD; Cabibi D; Craxì A
    Liver Int; 2012 Oct; 32(9):1443-50. PubMed ID: 22764879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
    Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
    J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C.
    Akcam FZ; Tigli A; Kaya O; Ciris M; Vural H
    J Interferon Cytokine Res; 2012 Dec; 32(12):570-4. PubMed ID: 23067363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoiesis, erythropoietin and blood lead levels.
    Liberatori R; Romeo R; Porcelli B; Barabesi L; Sartorelli P
    G Ital Med Lav Ergon; 2011; 33(1):37-40. PubMed ID: 21417137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study.
    Manolakopoulos S; Bethanis S; Liapi C; Stripeli F; Sklavos P; Margeli A; Christidou A; Katsanika A; Vogiatzakis E; Tzourmakliotis D; Theocharis S
    BMC Gastroenterol; 2007 May; 7():17. PubMed ID: 17540037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
    Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A
    Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
    Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.